You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科興製藥(688136.SH)業績快報:2020年度淨利降13.17%至1.39億元
格隆匯 02-26 18:19

格隆匯2月26日丨科興製藥(688136.SH)披露2020年度業績快報,報吿期內,公司實現營業收入12.20億元,同比增加2.48%;歸屬於母公司所有者的淨利潤1.39億元,同比下降13.17%;基本每股收益0.93元,同比下降13.08%。

報吿期末,公司財務狀況良好,總資產23.69億元,較上年期末增加100.77%;歸屬於上市公司股東的所有者權益18.298億元,較上年期末增加162.77%。

報吿期內,公司受疫情影響整體增速有所放緩但銷售繼續保持增長態勢。公司歸屬於母公司所有者的淨利潤下降的主要原因是:1、公司專注高端生物藥的研發與生產,通過加大產品研發投入,提升技術實力和產品競爭力,致使研發費用增加;2、2020年下半年美元對人民幣匯率持續走低,導致公司海外銷售業務產生匯兑損失。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account